Selective Serotonin Reuptake Inhibitors and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial

BACKGROUND: There is concern that selective serotonin reuptake inhibitors (SSRIs) substantially increase bleeding risk in patients taking anticoagulants. METHODS AND RESULTS: We studied 737 patients taking SSRIs in the ROCKET AF (Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Am Heart Assoc
Main Authors: Quinn, Gene R., Hellkamp, Anne S., Hankey, Graeme J., Becker, Richard C., Berkowitz, Scott D., Breithardt, Günter, Fava, Maurizio, Fox, Keith A. A., Halperin, Jonathan L., Mahaffey, Kenneth W., Nessel, Christopher C., Patel, Manesh R., Piccini, Jonathan P., Singer, Daniel E.
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2018
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6201450/
https://ncbi.nlm.nih.gov/pubmed/30371223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.118.008755
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker